Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine.

Nutirakendus aitab luua kontakti arstide ja HIV positiivsete inimeste vahel. Nutirakendus aitab mugavalt organiseerida ravimite võtmise aegu, seadistada ainult Teile arusaadavad ja personaalseid meeldetuletusi, võimaldab saada arstilt tagasisidet ning panna aega vastuvõtule või analüüsidele.

Kõik uudised

Arhiiv

✕

10 jaanuar 2018

3699

Marijuana may help HIV patients keep mental stamina longer

Marijuana may help HIV patients keep mental stamina longer

A chemical found in marijuana, known as tetrahydrocannabinol, has been found to potentially slow the process in which mental decline can occur in up to 50 percent of HIV patients.

10 jaanuar 2018

3523

Researchers Develop Way to Deliver a Week's Worth of HIV Drugs in One Dose

Researchers Develop Way to Deliver a Week's Worth of HIV Drugs in One Dose

The polymer matrices achieved systemic drug levels of all 3 antiretrovirals for up to 7 days after a single administration. Researchers selected the 3 antiretrovirals drugs because of their supporting efficacy either alone or in combination of maintenance therapy.

9 jaanuar 2018

3780

Florida to Roll Out Free PrEP by the end of 2018

Florida to Roll Out Free PrEP by the end of 2018

Truvada as PrEP, or pre-exposure prophylaxis, has been available at 16 county health departments for several months, but by the end of this year, all 67 county departments will offer the daily pill to people at risk for HIV.

9 jaanuar 2018

3418

Immediate HIV Treatment Has Little Impact on Risk of Future Drug Resistance

Immediate HIV Treatment Has Little Impact on Risk of Future Drug Resistance

Starting antiretroviral therapy immediately rather waiting until a person's CD4 count falls below 500 cells/µL has almost no impact on the person's risk of developing antiretroviral resistance over the next seven years, according to the new study.

29 detsember 2017

5703

Gene therapy could provide long-term protection against HIV

Gene therapy could provide long-term protection against HIV

Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor genes to make cells that can detect and destroy HIV-infected cells.

29 detsember 2017

6411

Teva Launches Generic Reyataz

Teva Launches Generic Reyataz

Teva announced the launch of Atazanavir Sulfate Capsules, the generic version of Bristol-Myers Squibb's Reyataz.

28 detsember 2017

6117

Life expectancy in Zimbabwe shoots up, HIV infection drop

Life expectancy in Zimbabwe shoots up, HIV infection drop

Life expectancy in the country has shot up from 37 years to 59 while a significant drop in new HIV infections has been recorded. The Minister of Health said his ministry was working hard as infant mortality and maternal mortality had also significantly dropped while life ...

28 detsember 2017

5403

Martin Shkreli's ex-lawyer found guilty of financial fraud

Martin Shkreli's ex-lawyer found guilty of financial fraud

Shkreli became notorious in 2015 when he raised the price of anti-parasitic drug Daraprim to $750 a pill, from $13.50, as chief executive of Turing Pharmaceuticals -- and got the nickname "Pharma bro." The price hike is not related to the criminal case.

27 detsember 2017

8708

In England half of young people do not use condoms for sex with new partner

In England half of young people do not use condoms for sex with new partner

One in 10 sexually active 16 to 24-year-olds, the age group that accounted for 59% of chlamydia and gonorrhoea diagnoses in England last year, said they had never used a condom. 47% of sexually active young people have had sex with someone new for the first time without ...

27 detsember 2017

5348

Experimental vaccine blocks effects of heroin

Experimental vaccine blocks effects of heroin

"By eliciting antibodies that bind with heroin in the blood, the vaccine aims to block the euphoria and addictive effects," said Dr. Gary Matyas, Chief of Adjuvants and Formulations for the U.S. Military Research Program. "We hope to give people a window so they can overcome ...

1...47 48 49 50 51...116